NOVEL CHOLESTEROL METABOLITE, 5-CHOLESTEN, 3BETA-25-DIOL, DISULFATE (25HCDS) FOR THERAPY OF METABOLIC DISORDERS, HYPERLIPIDEMIA, DIABETES, FATTY LIVERS DISEASES AND ATHEROSCLEROSIS

• 收藏
• 分享

专利权人:

VIRGINIA COMMONWEALTH UNIVERSITY

发明人:

Shunlin Ren

申请号：

US15728827

公开号：

US20180127457A1

申请日:

2017.10.10

申请国别(地区):

US

年份:

2018

代理人:

摘要：

5-cholesten, 3β,25-diol, disulfate (25HCDS) has been found to be an authentic PPARγ agonist and LXR antagonist, and is used for the therapy of lipid disorders and inflammatory diseases, including without limitation fatty liver, inflammatory bowel, and atherosclerotic diseases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/